Ependymal cell neuromyelitis optica aquaporin-4 cilia sub-ventricular zone Treatment response Area postrema syndrome MRI Children Breastfeeding Ependymal cell Blood brain barrier Propensity score Microenvironment Aquaporin-4-IgG AQP4-IgG Sub-ventricular zone Connexins Animal model Post-partum ERRα CRMP5 Estradiol Aquaporin-4 antibody Circadian clock Pallidin Neuromyelitis optica spectrum disorder T follicular helper cells T follicular regulatory cells B cells rituximab Clinically isolated syndrome CIS Hippocampus Microglia Demyelination Optic neuritis Optogenetic CD14 Neuromyelitis optica spectrum disorders Phosphorylation MOG Endocannabinoid system Autoimmune diseases Sample Spotty Neuromyelitis optica spectrum disorders NMOSD B cells Glutamate Neuromyelitis optica spectrum disorder MOGAD CP Molecular biology Glia Neurite outgrowth Disease-modifying treatments Neuroinflammation Neuromyelitis optica Reproductive assistance Rituximab Autoantibodies Perceptual learning Bright Multiple sclerosis MS Sleep/wake CP Neuroscience Bone GABA Drosophila GSK-3β T follicular regulatory cells Neuraxial analgesia Cannabinoid receptor type 2 Nonactive multiple sclerosis Optic neuritis ON NMOSD Multiple sclerosis Myelitis Amino acid Aquaporin-4 antibodies Central nervous system LAT1 Prostate cancer Anti-GFAP encephalomyelitis T follicular helper cells Adult neurogenesis Sex hormones MOG-IgG associated disorders MOGAD Collapsing response mediator protein Longitudinally extensive transverse myelitis COVID-19 Cilia Quality Cannabinoid receptor type 2 Endocannabinoid system Microglia Neuroinflammation Myelin oligodendrocyte glycoprotein Blood-brain barrier MOG antibodies Lateral diffusion Immunosuppressant Registry Pregnancy Aquaporin-4 Disease modifying treatments Prognosis Database Biobank Astrocyte Relapses Progesterone Olfaction Structural plasticity